ANAL MELANOMA

Clinical trials for ANAL MELANOMA explained in plain language.

Never miss a new study

Get alerted when new ANAL MELANOMA trials appear

Sign up with your email to follow new studies for ANAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail aims to prevent rare melanoma recurrence

Disease control Ongoing

This phase II trial tests whether adding cabozantinib to the immunotherapy drug nivolumab can prevent mucosal melanoma from returning after surgery. About 101 patients with resected mucosal melanoma will receive either nivolumab alone or nivolumab plus cabozantinib. The study aim…

Matched conditions: ANAL MELANOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Aug 06, 2026 00:00 UTC

ANAL MELANOMA

Get alerted when new ANAL MELANOMA trials appear

New drug cocktail aims to prevent rare melanoma recurrence